Efficacy of drug‐coated balloon angioplasty after directional coronary atherectomy for coronary bifurcation lesions ( DCA / DCB registry)

2020 ◽  
Author(s):  
Shunsuke Kitani ◽  
Yasumi Igarashi ◽  
Etsuo Tsuchikane ◽  
Shigeru Nakamura ◽  
Yoshitane Seino ◽  
...  
Keyword(s):  
Balloon Angioplasty ◽  
Coronary Bifurcation ◽  
Coronary Bifurcation Lesions ◽  
Bifurcation Lesions ◽  
Directional Coronary Atherectomy ◽  
Drug Coated Balloon

Balloon angioplasty of coronary bifurcation lesions: The kissing balloon technique

1986 ◽  
Vol 12 (2) ◽  
pp. 124-138 ◽  
Author(s):  
Barry S. George ◽  
Richard K. Myler ◽  
Simon H. Stertzer ◽  
David A. Clark ◽  
Gilles Cote ◽  
...  
Keyword(s):  
Balloon Angioplasty ◽  
Coronary Bifurcation ◽  
Coronary Bifurcation Lesions ◽  
Kissing Balloon Technique ◽  
Balloon Technique ◽  
Bifurcation Lesions

Dedicated Bifurcation Stents Strategy

2009 ◽  
Vol 4 (1) ◽  
pp. 70
Author(s):  
Chen Shao-Liang ◽  
Imad Sheiban ◽  
◽  
Keyword(s):  
Interventional Cardiology ◽  
Daily Practice ◽  
Side Branch ◽  
Control Groups ◽  
Coronary Bifurcation ◽  
Percutaneous Approach ◽  
Coronary Bifurcation Lesions ◽  
Drug Eluting ◽  
Bifurcation Lesions ◽  
Provisional Stenting

Coronary bifurcation lesions represent an area of ongoing challenges in interventional cardiology, mainly due to the higher rate of residual stenosis and restenosis at the side branch ostium. Multiple two-stent bifurcation strategies, including T-stenting, V-stenting, simultaneuos kissing stenting, culotte stenting and classic crush techniques, have no advantages over one-stent techniques. This led to provisional stenting being considered as a mainstream approach, based on the results of numerous randomised trials. Dedicated bifurcation stents have been designed specifically to treat coronary bifurcations with the aim of addressing some of the shortcomings of the conventional percutaneous approach and facilitating the provisional approach. The development of more drug-eluting platforms and larger studies with control groups demonstrating their clinical applicability, efficacy and safety are required before these stents are widely incorporated into daily practice.

Sign in / Sign up

Export Citation Format

Share Document